High levels of PD-L1 on platelets of NSCLC patients contributes to the pharmacological activity of Atezolizumab by Chiara Colarusso, Anna Falanga, Michela Terlizzi, Ilaria De Rosa, Pasquale Somma, Eduardo Maria Sommella, Vichy Caponigro, Luigi Panico, Emanuela Salviati, Pietro Campiglia, Giuseppe Salatiello, Teresa Tramontano, Piera Maiolino, Aldo Pinto, Rosalinda Sorrentino

Get full text